Dexcom (DXCM) Other financing activities (2018 - 2026)

Dexcom (DXCM) has 9 years of Other financing activities data on file, last reported at -$1.9 million in Q1 2026.

• On a quarterly basis, Other financing activities fell 11.76% year-over-year to -$1.9 million in Q1 2026; TTM through Mar 2026 was -$7.2 million, a 20.0% decrease from a year earlier, with the FY2025 full-year figure at -$7.0 million, up 46.15% from the prior year.
• Other financing activities for Q1 2026 stood at -$1.9 million, roughly flat from -$1.9 million in the prior quarter.
• Over the last five years, Other financing activities for DXCM reached as high as $4.9 million in Q4 2023 and fell as low as -$8.7 million in Q1 2024.
• Historically, Other financing activities has averaged -$2.2 million across 5 years, with a median of -$1.7 million in 2025.
• Across the five-year window, Other financing activities sank 975.0% in 2022 and surged 590.0% in 2023, its largest moves.
• Year by year, Other financing activities stood at -$1.0 million in 2022, then jumped by 590.0% to $4.9 million in 2023, then tumbled by 132.65% to -$1.6 million in 2024, then decreased by 18.75% to -$1.9 million in 2025, then changed by 0.0% to -$1.9 million in 2026.
• Per Business Quant data, the three most recent Other financing activities figures were -$1.9 million in Q1 2026, -$1.9 million in Q4 2025, and -$1.7 million in Q3 2025.